PROVIDER PROFILE · NPI 1013061886

Richard BeckermanM.D.

PRACTICEFOXHALL OB GYN ASSOC PCSee all providers at this practice →

Obstetrics & GynecologyWashington, DCI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

Distinct HCPCS

Medicare payment

$3K

Peer benchmark

Total Medicare services vs. 107 Obstetrics & Gynecology providers in DC — above median (cohort median 80).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$13K

Distinct drugs

Brand share

46.6%

Top prescribed drugs

Estrogens, Conjugated22 claims

Estradiol19 claims

Progesterone, Micronized19 claims

Clobetasol Propionate14 claims

Raloxifene Hcl14 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$302

Payment records

By payment type

Food and Beverage$302

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 090005

Hospital

REFERRAL NETWORK

Where Richard Beckerman's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD	17	37
LUCY WEBB HAYES NATIONAL TRAINING SCHOOL FOR DEACONESSES & MISSIONARIE	14	22
Laboratory Corporation Of America Holdings Clinical Laboratory · Burlington, NC	11	17

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history